Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Dec 9, 2016 (Close)|
|Price (Rs)673.00||Open (Rs) 679.95||High (Rs) 682.15||Low (Rs) 671.00|
|% Change-0.38||Volume 335,028||Value (Rs) 226,544,386||52-Week H/L 898.00 / 572.40|
|Live NSE Quotes||Dec 9, 2016 (Close)|
|Price (Rs)673.00||Open (Rs) 678.00||High (Rs) 682.80||Low (Rs) 671.25|
|% Change-0.40||Volume 3,298,719||Value (Rs) 2,230,627,969||52-Week H/L 898.45 / 571.90|
|EPS (Rs)* 30.74||P/E Ratio (x) 21.89||Market Cap (Rs m) 1,619,744.77||P/BV (x) 5.16|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|SUN PHARMA Stock Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Barring China (down 0.3%), major global indices closed on a positive note. The US equity markets closed at a record on Friday as the broad indices witnessed its best winning streak since June 2014.
Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.
Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.
Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.
Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.More Views on News
The perceived benefits of demonetisation are actually turning out to be way lower than expected. This, even as its costs mount higher and higher with each passing day.
One data point and one clarification from the RBI, essentially tell us that the theories that were being offered in favour of demonetisation were totally wrong.
Asad Dossani discusses how you can profit from swings in the price of gold. On Saturday at 10am, he will hold a live question and answer session, where you can learn if the VMS system is right for you.
A hard-working employee has already sacrificed cash on his salary day.
What will be the long term impact from this move on black money and counterfeiting?More